Stock Events

Acadia Pharmaceuticals (ACAD) Q1 2019 Earnings

ACAD +0.86%
26FebConfirmed
Q2 2018
Q3 2018
Q4 2018
Q1 2019
-0.57
-0.53
-0.48
-0.44

Details

Expected EPS
-0.55
Actual EPS
-0.5
Surprise EPS
0.05
Surprise Percent
+9.09%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.5 per share for Q1 2019.

0 Comments

Share your thoughts